Healthcare provider profile · identity verified

Carter A Aune, M.D.

Family Practice · HARTFORD, WI · NPI 1174580724

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	307	85
Oxycodone Hcl	Oxycodone Hcl	177	22
Metoprolol Succinate	Metoprolol Succinate	171	47
Pantoprazole Sodium	Pantoprazole Sodium	164	51
Lisinopril	Lisinopril	159	46
Albuterol Sulfate Hfa	Albuterol Sulfate	149	42
Amlodipine Besylate	Amlodipine Besylate	148	44
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	148	28
Prednisone	Prednisone	133	82
Levothyroxine Sodium	Levothyroxine Sodium	119	25
Metformin Hcl Er	Metformin Hcl	117	37
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	104	11
Zolpidem Tartrate	Zolpidem Tartrate	103	19
Tamsulosin Hcl	Tamsulosin Hcl	95	28
Gabapentin	Gabapentin	93	31
Losartan Potassium	Losartan Potassium	92	33
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	90	37
Furosemide	Furosemide	90	35
Omeprazole	Omeprazole	90	27
Simvastatin	Simvastatin	90	25
Methylprednisolone	Methylprednisolone	87	73
Alprazolam	Alprazolam	84	13
Meloxicam	Meloxicam	78	24
Tizanidine Hcl	Tizanidine Hcl	76	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	73	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	71	18
Tramadol Hcl	Tramadol Hcl	71	15
Lorazepam	Lorazepam	70	14
Cefuroxime	Cefuroxime Axetil	69	54
Warfarin Sodium	Warfarin Sodium	69	16
Montelukast Sodium	Montelukast Sodium	68	17
Trazodone Hcl	Trazodone Hcl	65	18
Escitalopram Oxalate	Escitalopram Oxalate	59	16
Rosuvastatin Calcium	Rosuvastatin Calcium	59	15
Carvedilol	Carvedilol	56	17
Eliquis	Apixaban	56	16
Azithromycin	Azithromycin	55	48
Fluticasone Propionate	Fluticasone Propionate	50	20
Hydrochlorothiazide	Hydrochlorothiazide	50	15
Allopurinol	Allopurinol	49	15
Duloxetine Hcl	Duloxetine Hcl	46	13
Diclofenac Sodium	Diclofenac Sodium	42	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	42	11
Jardiance	Empagliflozin	40	13
Pravastatin Sodium	Pravastatin Sodium	40	suppressed
Ozempic	Semaglutide	39	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	39	suppressed
Sertraline Hcl	Sertraline Hcl	38	suppressed
Metformin Hcl	Metformin Hcl	36	13
Finasteride	Finasteride	34	suppressed
Spironolactone	Spironolactone	34	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	34	28
Ezetimibe	Ezetimibe	32	suppressed
Solifenacin Succinate	Solifenacin Succinate	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Cefdinir	Cefdinir	28	24
Lidocaine	Lidocaine	28	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Clonazepam	Clonazepam	25	suppressed
Diazepam	Diazepam	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	11
Doxycycline Hyclate	Doxycycline Hyclate	24	23
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	22
Bupropion Xl	Bupropion Hcl	23	suppressed
Famotidine	Famotidine	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Premarin	Estrogens, Conjugated	23	suppressed
Atenolol	Atenolol	22	suppressed
Clindamycin Hcl	Clindamycin Hcl	22	21
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Celecoxib	Celecoxib	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Mupirocin	Mupirocin	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	13
Glimepiride	Glimepiride	16	suppressed
Hydrocortisone	Hydrocortisone	16	12
Pregabalin	Pregabalin	16	suppressed
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	14
Nystatin	Nystatin	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Baclofen	Baclofen	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Polymyxin B Sul-Trimethoprim	Polymyxin B Sulf/Trimethoprim	13	13
Adderall	Dextroamphetamine/Amphetamine	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Dexmethylphenidate Hcl Er	Dexmethylphenidate Hcl	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Junel	Norethindrone Ac/Eth Estradiol	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Potassium Chloride	Potassium Chloride	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Topiramate	Topiramate	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error